Evidence map›Paper›PMID 36414294›Full record

ArticleBMJ open2022

Vocal biomarker predicts fatigue in people with COVID-19: results from the prospective Predi-COVID cohort study.

Abir Elbéji, Lu Zhang, Eduardo Higa, Aurélie Fischer, Vladimir Despotovic, Petr V Nazarov, Gloria Aguayo, Guy Fagherazzi

Registry-linked trialAbstract read
In one paragraph

Article in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04380987 (Luxembourg Cohort of Positive Patients for COVID-19), which is not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04380987 completednot on this map

Luxembourg Cohort of Positive Patients for COVID-19: a Stratification Study to Predict Patient Prognosis

TypeobservationalSponsorLuxembourg Institute of HealthRan2020 to 2024Enrolled1,366ConditionsCovid19ArmsBiological sampling
3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abir ElbéjiDepartment of Precision Health, Luxembourg Institute of Health, 1A-B, rue Thomas Edison, L-1445 Strassen, Luxembourg.ORCID 0000-0002-5293-4337
Lu ZhangDepartment of Precision Health, Luxembourg Institute of Health, 1A-B, rue Thomas Edison, L-1445 Strassen, Luxembourg.
Eduardo HigaDepartment of Precision Health, Luxembourg Institute of Health, 1A-B, rue Thomas Edison, L-1445 Strassen, Luxembourg.
Aurélie FischerDepartment of Precision Health, Luxembourg Institute of Health, 1A-B, rue Thomas Edison, L-1445 Strassen, Luxembourg.
Vladimir DespotovicBioinformatics Platform, Luxembourg Institute of Health, 1A-B, rue Thomas Edison, L-1445 Strassen, Luxembourg.
Petr V NazarovBioinformatics Platform, Luxembourg Institute of Health, 1A-B, rue Thomas Edison, L-1445 Strassen, Luxembourg.
Gloria AguayoDepartment of Precision Health, Luxembourg Institute of Health, 1A-B, rue Thomas Edison, L-1445 Strassen, Luxembourg.ORCID 0000-0002-5625-1664
Guy FagherazziDepartment of Precision Health, Luxembourg Institute of Health, 1A-B, rue Thomas Edison, L-1445 Strassen, Luxembourg guy.fagherazzi@lih.lu.ORCID 0000-0001-5033-5966

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo develop a vocal biomarker for fatigue monitoring in people with COVID-19.

designProspective cohort study.

settingPredi-COVID data between May 2020 and May 2021.

participantsA total of 1772 voice recordings were used to train an AI-based algorithm to predict fatigue, stratified by gender and smartphone's operating system (Android/iOS). The recordings were collected from 296 participants tracked for 2 weeks following SARS-CoV-2 infection. PRIMARY AND SECONDARY OUTCOME MEASURES: Four machine learning algorithms (logistic regression, k-nearest neighbours, support vector machine and soft voting classifier) were used to train and derive the fatigue vocal biomarker. The models were evaluated based on the following metrics: area under the curve (AUC), accuracy, F1-score, precision and recall. The Brier score was also used to evaluate the models' calibrations.

resultsThe final study population included 56% of women and had a mean (±SD) age of 40 (±13) years. Women were more likely to report fatigue (p<0.001). We developed four models for Android female, Android male, iOS female and iOS male users with a weighted AUC of 86%, 82%, 79%, 85% and a mean Brier Score of 0.15, 0.12, 0.17, 0.12, respectively. The vocal biomarker derived from the prediction models successfully discriminated COVID-19 participants with and without fatigue.

conclusionsThis study demonstrates the feasibility of identifying and remotely monitoring fatigue thanks to voice. Vocal biomarkers, digitally integrated into telemedicine technologies, are expected to improve the monitoring of people with COVID-19 or Long-COVID. TRIAL REGISTRATION NUMBER: NCT04380987.

Indexed as

COVID-19AdultBiomarkersCohort StudiesFatigueFemaleHumansMaleMiddle AgedPost-Acute COVID-19 SyndromeProspective StudiesSARS-CoV-2BiomarkersCOVID-19Health informaticsPublic health

Identifiers

PMID36414294
PMCPMC9684280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.